1. Home
  2. VPG vs NNNN Comparison

VPG vs NNNN Comparison

Compare VPG & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VPG
  • NNNN
  • Stock Information
  • Founded
  • VPG 2009
  • NNNN 2021
  • Country
  • VPG United States
  • NNNN Germany
  • Employees
  • VPG N/A
  • NNNN N/A
  • Industry
  • VPG Electrical Products
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • VPG Technology
  • NNNN Health Care
  • Exchange
  • VPG Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • VPG 268.9M
  • NNNN 267.7M
  • IPO Year
  • VPG N/A
  • NNNN 2025
  • Fundamental
  • Price
  • VPG $25.33
  • NNNN $8.01
  • Analyst Decision
  • VPG Hold
  • NNNN
  • Analyst Count
  • VPG 1
  • NNNN 0
  • Target Price
  • VPG $31.00
  • NNNN N/A
  • AVG Volume (30 Days)
  • VPG 186.5K
  • NNNN 44.5K
  • Earning Date
  • VPG 05-06-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • VPG N/A
  • NNNN N/A
  • EPS Growth
  • VPG N/A
  • NNNN N/A
  • EPS
  • VPG 0.23
  • NNNN 0.06
  • Revenue
  • VPG $297,480,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • VPG N/A
  • NNNN N/A
  • Revenue Next Year
  • VPG $6.35
  • NNNN N/A
  • P/E Ratio
  • VPG $112.37
  • NNNN $140.27
  • Revenue Growth
  • VPG N/A
  • NNNN 21.95
  • 52 Week Low
  • VPG $18.57
  • NNNN $5.18
  • 52 Week High
  • VPG $35.11
  • NNNN $8.22
  • Technical
  • Relative Strength Index (RSI)
  • VPG 51.21
  • NNNN N/A
  • Support Level
  • VPG $25.45
  • NNNN N/A
  • Resistance Level
  • VPG $27.00
  • NNNN N/A
  • Average True Range (ATR)
  • VPG 0.96
  • NNNN 0.00
  • MACD
  • VPG -0.18
  • NNNN 0.00
  • Stochastic Oscillator
  • VPG 8.55
  • NNNN 0.00

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: